The Cost Implications of New Weight Loss Treatments for Plan Sponsors
See this article by AlignRx chief pharmacy officer Beckie Fenrick as it originally appeared in BenefitsPRO. With obesity rates in the United States having tripled since the 1980s, the health care system now faces an annual cost of $173 billion due to obesity-related complications, such as heart disease, hypertension, joint pain and certain types of […]
The Cost Implications of New Weight Loss Treatments for Plan Sponsors Read More »
